Twist Bioscience Corp vs United States Natural Gas Fund — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while United States Natural Gas Fund trades at $10.4. The key difference: Twist Bioscience Corp is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| TWST | UNG | |
|---|---|---|
Market Cap | $5.45B | — |
Sector | Health | Commodities - Energy |
52-Week High | $102.88 | $16.90 |
52-Week Low | $24.16 | $10.15 |
Enterprise Value | $5.37B | — |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →